August 2017

Providence Cancer Center is currently conducting more than 150 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.

New immunotherapy studies for advanced melanoma

Providence Cancer Center is an international leader in melanoma research and treatment. Two new studies of investigational and FDA-approved immunotherapies for melanoma are opening at Providence soon:  Opening in July: A study of nivolumab and ipilimumab in combination versus alone after complete resection of stage IIIb/c/d or stage IV melanoma Opening in August: A study comparing IMCgp100 to other treatments in HLA-A*0201-positive patients with previously untreated advanced uveal melanoma Read More About These Studies

All current open studies:

Brain Cancer Breast Cancer Gastrointestinal Cancers  Genitourinary Cancers Gynecologic Cancers

Hematologic Cancers Lung Cancer Melanoma Oral, Head and Neck Cancers Phase 1 Trials

New studies are posted frequently - please check our  website for a complete list of our current studies. For more information, call 503-215-2614.

Refer A Patient

Email Our Team

See All Open Studies

Find Immunotherapy Research Info

Website     Join Our Team     About Us     Subscribe to Email